Serotonergic modulation of the circuits and cell-types of the lateral habenula
Project Number3R01MH133608-02S1
Contact PI/Project LeaderWALLACE, MICHAEL L
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Project Summary
Serotonin (5-HT)-releasing neurons in the mammalian mid/hindbrain are critical for fundamental behaviors and
cognitive processes, including emotional control, arousal, and motor control. Selective serotonin reuptake
inhibitors (SSRIs) increase brain 5-HT levels and are the most commonly prescribed treatment for major-
depression in humans. However, our understanding of the mechanisms by which 5-HT influences synapses,
cells, and circuits is limited, prohibiting improvement of depression therapeutics. A major target of 5-HT
neurons is the lateral habenula (LHb), a subcortical structure principally implicated in evaluating the outcome
(positive or negative) of an action. The LHb is the only brain region that shows consistent hyperactivity several
rodent models of chronic stress and additional studies have recently refined this observation indicating “burst-
firing” in LHb is causally related several behavioral phenotypes (including anhedonia) following chronic stress.
Recently, using single-cell transcriptome wide sequencing, we genetically defined the neuronal subclasses
within the LHb for the first time revealing cell-type specific expression of both 5-HT receptors and genes
related to burst-firing. Our central hypothesis is that 5-HT release dynamically modulates the habenula circuit
though neuron-type specific expression of 5-HT receptors and that burst-firing in specific, genetically defined
LHb neuron-types is required for anhedonia following chronic stress. This proposal seeks to 1) identify the
neuron-type(s) in the LHb that exhibit burst-firing in vitro and in vivo, 2) determine how 5-HT modulates
neuron-types and local connectivity within the LHb and 3) define the neuron-types in the LHb required for
chronic stress induced anhedonia. By revealing how 5-HT modulates habenular circuits, the proposed work
will provide a comprehensive understanding of the cellular and circuit targets of this important neuromodulator.
These findings will form the foundation for understanding the principal mechanisms by which SSRIs impact
synapses and circuits of the LHb, uncovering new avenues for therapeutic intervention in major depressive
disorder and other neurological disorders treated by these drugs.
Public Health Relevance Statement
Project Narrative
Release of neuromodulators, such as serotonin (5-HT), have profound effects on neural circuits and behavior
and change following chronic stress. Here, we propose to dissect the selective cellular and circuit effects of a
neuromodulator, 5-HT, on specific neuronal subtypes within the lateral habenula (LHb) in vitro and in vivo in
mice. Furthermore, following chronic stress we will examine how a common treatment for depression
(administration of selective serotonin reuptake inhibitors (SSRIs)) modifies the temporal dynamics of 5-HT and
effects neuronal activity in the LHb in vivo to understand how activity of specific LHb neuron-types change and
effect behavior.
No Sub Projects information available for 3R01MH133608-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01MH133608-02S1
Patents
No Patents information available for 3R01MH133608-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01MH133608-02S1
Clinical Studies
No Clinical Studies information available for 3R01MH133608-02S1
News and More
Related News Releases
No news release information available for 3R01MH133608-02S1
History
No Historical information available for 3R01MH133608-02S1
Similar Projects
No Similar Projects information available for 3R01MH133608-02S1